Nives Carenini Selected Research

Nives Carenini Research Topics

Disease

20	Neoplasms (Cancer) 05/2024 - 12/2002
20	Carcinoma (Carcinomatosis) 01/2023 - 12/2002
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 03/2011
3	Melanoma (Melanoma, Malignant) 06/2014 - 12/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 11/2008
2	Glioblastoma (Glioblastoma Multiforme) 12/2002 - 03/2002
1	Lung Neoplasms (Lung Cancer) 05/2024
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Breast Neoplasms (Breast Cancer) 02/2014
1	Hypersensitivity (Allergy) 01/2011
1	Genomic Instability 08/2008
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2008
1	Osteosarcoma (Osteogenic Sarcoma) 12/2002
1	Glioma (Gliomas) 03/2002

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 12/2002
9	PlatinumIBA 01/2022 - 07/2003
5	ST 1481 (Gimatecan)IBA 04/2008 - 12/2002
3	Drug CombinationsIBA 07/2019 - 05/2005
3	LigandsIBA 06/2014 - 03/2006
2	Ubiquitin-Specific ProteasesIBA 01/2022 - 01/2022
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 06/2014
2	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2014
2	Platinum Compounds (Compounds, Platinum)IBA 11/2016 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 03/2016 - 08/2008
2	IntegrinsIBA 12/2012 - 08/2012
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2012 - 04/2003
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2011 - 07/2008
2	BBR 3464 (BBR3464)IBA 01/2006 - 07/2003
2	CamptothecinIBA 04/2003 - 12/2002
2	Topotecan (Hycamtin)FDA LinkGeneric 04/2003 - 12/2002
1	EstersIBA 01/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	Conditioned Culture MediaIBA 07/2022
1	Peptides (Polypeptides)IBA 07/2022
1	CurcuminIBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	UbiquitinIBA 01/2022
1	caffeic acid phenethyl esterIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Histone Deacetylase 6IBA 01/2020
1	ricolinostatIBA 01/2020
1	AZD 6244IBA 01/2020
1	statticIBA 07/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2019
1	SB 203580IBA 07/2019
1	selinexorIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Messenger RNA (mRNA)IBA 03/2016
1	ErbB Receptors (EGF Receptor)IBA 03/2016
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 03/2016
1	Small Interfering RNA (siRNA)IBA 03/2016
1	ChemokinesIBA 06/2014
1	Temozolomide (Temodar)FDA LinkGeneric 06/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2014
1	CC ChemokinesIBA 06/2014
1	olaparibIBA 02/2014
1	PeptidomimeticsIBA 12/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2012
1	TriazolesIBA 08/2012
1	aminoprolineIBA 08/2012
1	Ethylene Glycol (Monoethylene Glycol)IBA 08/2012
1	AmidesIBA 08/2012
1	PoisonsIBA 01/2012
1	EnzymesIBA 01/2012
1	tyrosyl-DNA phosphodiesteraseIBA 01/2012
1	3- (3'- adamantan- 1- yl- 4'- methoxybiphenyl- 4- yl)- 2- propenoic acidIBA 03/2011
1	3- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA 03/2011
1	RetinoidsIBA 03/2011
1	CoumarinsIBA 05/2010
1	ResveratrolIBA 05/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2010
1	multidrug resistance-associated protein 1IBA 04/2010
1	DNA (Deoxyribonucleic Acid)IBA 02/2010
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2008
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2008
1	CPG-oligonucleotideIBA 04/2008
1	OligodeoxyribonucleotidesIBA 04/2008
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2006
1	oblimersen (G3139)IBA 05/2005
1	Apoptosis Regulatory ProteinsIBA 05/2005
1	Antisense OligonucleotidesIBA 05/2005
1	Cytostatic AgentsIBA 04/2003
1	Hormones (Hormone)IBA 04/2003
1	Topoisomerase I InhibitorsIBA 03/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 03/2002
1	Castration 01/2020
1	Drug Therapy (Chemotherapy) 05/2005
1	Oral Administration 12/2002